Skip to main content
. 2023 Jan 1;16(2):109–117. doi: 10.70252/VWUK7519

Table 4.

Means and standard deviations of outcome measures

Baseline 24h 48h 72h
Interleukin-6 (ng/dL) Placebo −0.6 ± 4.51 −0.03 ± 6.22 4.88 ± 6.53 3.11 ± 4.26
Low 0.75 ± 1.31 2.01 ± 2.44 0.35 ± 2.22 0.47 ± 5.61
High 0.44 ± 0.51 1.69 ± 1.75 1.34 ± 1.34 −0.79 ± 5.34

Handgrip (kg) Placebo 33.4 ± 8.8 35.2 ± 8.7 35.3 ± 8.8 36.1 ± 8.4
Low 32.2 ± 8.3 34.3 ± 11.1 33.6 ± 10 34.1 ± 9
High 34.7 ± 8.6 30.6 ± 8 34 ± 8.3 34.9 ± 9.9

Bicep Curl (kg) Placebo 26.4 ± 13 19.3 ± 15.8 23.6 ± 16.4 23.9 ± 14.5
Low 24.8 ± 14.7 21.8 ± 16.8 25.3 ± 17.7 26.5 ± 16.7
High 29.1 ± 13.2 23.3 ± 15.9 24.7 ± 16.7 26.3 ± 17.1

Pain (a.u.) Placebo 0 ± 0 27.3 ± 14.9 23 ± 19.4 7.6 ± 7.4
Low 0 ± 0 23.5 ± 22.3 8.5 ± 10.1 3.8 ± 4.5
High 0.3 ± 0.5 28 ± 25.6 13 ± 14.4 9.5 ± 9.1

Range of Motion (°) Placebo 171.5 ± 8.5 164.8 ± 10 166 ± 8.7 168.5 ± 8.3
Low 176 ± 7 163.8 ± 13.5 166.3 ± 8.8 172 ± 2.9
High 174.3 ± 5 163.8 ± 8.5 164.5 ± 5.2 166.8 ± 2.4